000			02075 a2200625 4500
005			20250514015642.0
264		0	_c20020102
008			200201s 0 0 eng d
022			_a1464-8431
040			_aNLM _beng _cNLM
100	1		_aLeone, P
245	0	0	_aGlobal CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease. _h[electronic resource]
260			_bCurrent opinion in molecular therapeutics _cAug 1999
300			_a487-92 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAcetates _xtherapeutic use
650	0	4	_aAcetazolamide _xtherapeutic use
650	0	4	_aAmidohydrolases _xdeficiency
650	0	4	_aAnimals
650	0	4	_aAspartic Acid _xanalogs & derivatives
650	0	4	_aBrain _xenzymology
650	0	4	_aBrain Edema _xetiology
650	0	4	_aCalcium Compounds
650	0	4	_aCanavan Disease _xdiagnosis
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCholesterol _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytomegalovirus _xgenetics
650	0	4	_aDNA, Recombinant _xadministration & dosage
650	0	4	_aDependovirus _xgenetics
650	0	4	_aFemale
650	0	4	_aFetal Diseases _xdiagnosis
650	0	4	_aGenetic Therapy
650	0	4	_aGenetic Vectors _xadministration & dosage
650	0	4	_aGlycerophospholipids _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInjections, Intraventricular
650	0	4	_aLiposomes _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMitochondria _xmetabolism
650	0	4	_aNerve Tissue Proteins _xdeficiency
650	0	4	_aOsmotic Pressure
650	0	4	_aPhosphatidylethanolamines
650	0	4	_aPrenatal Diagnosis
650	0	4	_aPrimates
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProtamines _xadministration & dosage
650	0	4	_aRats
700	1		_aJanson, C G
700	1		_aMcPhee, S J
700	1		_aDuring, M J
773	0		_tCurrent opinion in molecular therapeutics _gvol. 1 _gno. 4 _gp. 487-92
999			_c11628378 _d11628378